PXB-SHIZUKU
Live / Registered — Registered (as of 17 Dec 2024)
What this means for you
Registered since 17 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79378897
- Registration number
- 7602251
- Mark type
- Stylized text
- Filed
- 25 Jul 2023
- Published for opposition
- 15 Oct 2024
- Registered
- 17 Dec 2024
- Attorney of record
- Jeffrey H. Handelsman
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; biological preparations, other than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research use, other than for medical or veterinary purposes; cell culture medium for scientific or research use, other than for medical or veterinary use; cell culture conditioned medium for scientific or research use, other than for medical or veterinary purposes; supernatant of cell culture medium for scientific or research use, other than for medical or veterinary purposes; supernatant fluid of cell culture medium for scientific or research use, other than for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for human purposes; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for veterinary purposes; cells for medical or veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cell culture medium for medical and veterinary purposes; cell culture conditioned medium for medical and veterinary purposes; supernatant of cell culture medium for medical and veterinary purposes; supernatant fluid of cell culture medium for medical and veterinary purposes
Owner
Prosecution history
- 21 Jun 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 May 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 May 2025 — FINAL DISPOSITION PROCESSED
- 25 Apr 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 17 Mar 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 12 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 12 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 17 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED